🇺🇸
United States · US · US:82260-466_483360bc-332c-6ccd-e063-6394a90a0b25
Besivance
Orange BookUNIISPLATC S01AE08
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerBausch & Lomb Americas Inc.
CountryUS (United States)
ATC codeS01AE08
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1182260466051 BOTTLE, DROPPER in 1 CARTON (82260-466-05) / 5 mL in 1 BOTTLE, DROPPER
Annotations
UNII (FDA Substance ID)
BFE2NBZ7NX
BESIFLOXACIN
RxCUI 819911
Orange Book
N022308
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "BFE2NBZ7NX",
"rxcui": "819911",
"inchikey": "QFFGVLORLPOAEC-SNVBAGLBSA-N",
"display_name": "BESIFLOXACIN",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "OPHTHALMIC",
"spl_meta": {
"ff971287-5610-4f15-8392-fc974e6ff646": {
"match": "brand_token",
"title": "BESIVANCE (BESIFLOXACIN) SUSPENSION [BAUSCH & LOMB AMERICAS INC.]",
"spl_version": "1",
"published_date": "2026-01-13"
}
},
"productid": "82260-466_483360bc-332c-6ccd-e063-6394a90a0b25",
"productndc": "82260-466",
"dosage_form": "SUSPENSION",
"orange_book": {
"appl_no": "022308",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 0.6% BASE",
"product_no": "001",
"approval_date": "May 28, 2009"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "BESIFLOXACIN",
"proprietary_name": "Besivance",
"active_ingred_unit": "mg/mL",
"application_number": "NDA022308",
"marketing_category": "NDA",
"nonproprietary_name": "Besifloxacin",
"start_marketing_date": "20260109",
"active_numerator_strength": "6"
}Related drugs
Other records sharing ATC code S01AE08.
Access this data programmatically
Query Besivance and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.